This supports the potential of compounded cyanocobalamin/SNAC as a practical alternative for patients who are injection/needle-averse , non-compliant with injections, or seeking a more convenient therapy even if their providers have traditionally used methylcobalamin in injectable form
Molecular Characteristics Compound Name: hGH Fragment 176191 CAS Number: 66004-57-7 Peptide Length: 16 amino acids Molecular Formula: C78H123N23O23 Molecular Weight: ~1817 g/mol Form: Lyophilized peptide powder Purity: 99% HPLC verified Stability Profile and Storage Recommendations Store lyophilized peptide at 20C Protect from moisture and direct light exposure Avoid repeated freezethaw cycles Reconstituted solutions should be refrigerated Handle using aseptic laboratory techniques Solubility and Reconstitution Options Sterile bacteriostatic water Sterile saline solutions Buffered aqueous laboratory solutions Biochemical assay buffers Laboratory-grade solvent systems Technical Specifications product Name hGH Fragment 176191 6mg brand BioPeptides cas 66004-57-7 purity 99% (HPLC verified) unit Size 6mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC and Mass Spectrometry molecular Structure Synthetic growth hormone fragment stability Stable when stored at 20C Analytical Validation and Quality Assurance High-performance liquid chromatography purity verification Mass spectrometry molecular weight confirmation Peptide structural integrity validation Batch-to-batch analytical consistency testing Peptide stability verification Regulatory and Compliance Statement hGH Fragment 176191 supplied by BioPeptides is intended strictly for laboratory and scientific research use only
These options are supported by extensive research, clinical experience, and regulatory frameworks designed to ensure patient safety and therapeutic efficacy
It should not be treated as a universal requirement for every peptide
For example, aluminum hydroxide salts, often used as vaccine adjuvants, have been found to abnormally persist within immune cells at the site of previous immunization, resulting in macrophagic myofasciitis lesions (168)
